Hemo Organic Ratios

Hemo Organic Ltd Ratios

The Hemo Organic Ltd Ratios page provides a complete fundamental analysis of Hemo Organic Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Hemo Organic Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Hemo Organic Ltd (NSE: , BSE: 524590) is currently trading at ₹13.07, with a market capitalization of ₹0. As a major player in the Process industries sector and Chemicals: specialty industry, Hemo Organic Ltd remains a key stock for fundamental analysis using Hemo Organic Ltd Ratios.

Hemo Organic Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Hemo Organic Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Hemo Organic Ltd Ratios.

Historically, the Hemo Organic Ltd P/E ratio has shown strong fluctuations:

The decline in Hemo Organic Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Hemo Organic Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Hemo Organic Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Hemo Organic Ltd P/S ratio currently stands at 0, an important part of Hemo Organic Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Hemo Organic Ltd P/S ratio indicates cautious market sentiment.

Hemo Organic Ltd Price to Cash Flow Ratio (P/CF)

The Hemo Organic Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Hemo Organic Ltd Price to Cash Flow Ratio:

The declining Hemo Organic Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Hemo Organic Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Hemo Organic Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Hemo Organic Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Hemo Organic Ltd EV/EBITDA ratio is currently 0, a key metric in Hemo Organic Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Hemo Organic Ltd EV/EBITDA indicates balanced valuation.

Hemo Organic Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Hemo Organic Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Hemo Organic Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Hemo Organic Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Hemo Organic Ltd Ratios Analysis Summary

The Hemo Organic Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Hemo Organic Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Hemo Organic Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.